Hta Austria - Austrian Institute For Health Technology Assessment Gmbh (aihta)

Name

Hta Austria - Austrian Institute For Health Technology Assessment Gmbh (aihta)

Legal name

HTA Austria - Austrian Institute for Health Technology Assessment GmbH

Website

https://aihta.at

Company type

Private

Founded year

2000

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Health Technology Assessment Services

NAICS

Testing Laboratories and Services (541380)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Misc Health & Allied Services, Nec (8090)

akta.pro primary industry

Economic Evaluation & Health Technology Assessment (Public Programs) (HLAJANAL)

akta.pro secondary industry

Health Technology Assessment (HTA) & Reimbursement Policy Bodies (HLAJACAF)

Keywords

• Health technology assessment
• Healthcare decision support
• Reimbursement evidence review
• Clinical effectiveness evaluation
• Health economic analysis

Headquarters

HQ city

Vienna

HQ country

Austria

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales

Distribution channels1 record

Marketing channels4 records

Core offering

AIHTA conducts independent health technology assessments for the Austrian healthcare system, producing systematic reviews, health economic evaluations, and rapid evidence reviews. Its deliverables include HTA Project Reports, Decision Support Documents for the Austrian Appraisal Board, Rapid Reviews, Horizon Scanning fact sheets in oncology, and Evaluation of Individual Medical Procedures (MEL) reports, all published free of charge through its open-access institutional repository.

Product overview

AIHTA (Austrian Institute for Health Technology Assessment) is an academic non-profit institute that produces health technology assessment reports and decision support documents to inform healthcare decision-making in Austria. The organisation offers a portfolio of research products including HTA Project Reports (comprehensive assessments of medical technologies, drugs, and procedures), Decision Support Documents for the Austrian Appraisal Board (evaluating medicines for reimbursement), Rapid Reviews (quick evidence assessments), and Horizon Scanning in Oncology reports (early evaluation of new cancer drugs). Key service offerings include Master's thesis supervision, genetic testing assessments, and hospital-based HTA for AI-based digital health technologies. All publications are freely accessible through the AIHTA Institutional Repository (eprints.aihta.at), an open-access platform built on GNU EPrints. The institute operates under a shareholder structure including Austrian federal and regional health funds, and produces outputs in both German and English.

Differentiator

Problem solved

Functional benefit

Products and services

• HTA Project Reports (HTA-Projektberichte) Comprehensive health technology assessment reports covering clinical effectiveness, safety, economic, organizational, and ethical aspects of medical technologies, drugs, devices, procedures, and health interventions. Produced for Austrian healthcare decision-makers and published open-access.
• Decision Support Documents for the Austrian Appraisal Board (Bewertungsboard) Structured assessments produced for the Austrian Appraisal Board evaluating effectiveness and safety of medicines and medical technologies to support national reimbursement decisions, including dedicated assessments of new oncological drugs and advanced therapies.
• Rapid Reviews Quick-turnaround evidence assessments on specific health technology topics for timely decision support, including systematic reviews on topics such as CGRP antagonists for migraine prevention, structured medication reviews, and infiltration therapies for musculoskeletal pain.
• Horizon Scanning in Oncology Early assessments of new oncological drugs conducted since 2009, including prioritisation reports and monthly fact sheets categorised using the ESMO Magnitude of Clinical Benefit Scale (MCBS) along with budget-impact calculations. From 2025, conducted in European cooperation under the EU HTA Regulation.
• Evaluation of Individual Medical Procedures (MEL Reports) Assessments of individual medical procedures and interventions covering various therapeutic technologies and procedures to support healthcare decision-making in Austria.
• Hospital-based HTA (HB-HTA) for AI-based Digital Health Technologies Structured prioritisation and rapid exploration framework for AI-based digital health technologies in Austrian hospitals, including the Topic Identification and Selection Process (TISP) and Rapid Exploration Reports (RERs).
• Genetic Testing in Austria Assessment Series Multi-part HTA project reports (Parts A, B, C) assessing genetic testing applications in Austria, including carrier screening, breast cancer diagnostics (PIK3CA/AKT1/PTEN/ESR1 alterations), and prioritisation criteria.

Segments3 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature5 records

Partnerships

15 partnerships are on record, tiered core and minor.

• Federal Ministry of Health (BMFG)coreStrategic or Co-development PartnerFederal Ministry of Health (BMFG) - Shareholder of AIHTA representing national government interest in health technology assessment for Austria.
• Main Association of Austrian Social Security Institutions (HVB)coreStrategic or Co-development PartnerMain Association of Austrian Social Security Institutions (Hauptverband) - Key stakeholder representing social health insurance institutions in Austria.
• Vienna Health Fund (Wiener Gesundheitsfonds)coreStrategic or Co-development PartnerVienna Health Fund - Regional health fund representing Vienna's healthcare financing interests.
• Lower Austria Health Fund (NÖGUS)coreStrategic or Co-development PartnerLower Austria Health Fund - Regional health fund for Lower Austria.
• Upper Austria Health Fund (OÖGAGES)coreStrategic or Co-development PartnerUpper Austria Health Fund (OÖ Gesundheitsfonds) - Regional health fund for Upper Austria.
• Salzburg Health and Social Region (SAGES)coreStrategic or Co-development PartnerSalzburg Health and Social Region (SAGES) - Regional health coordination body for Salzburg.
• Tyrol Health FundcoreStrategic or Co-development PartnerTyrol Health Fund (Tirol Gesundheitsfonds) - Regional health fund for Tyrol.
• Vorarlberg Health FundcoreStrategic or Co-development PartnerVorarlberg Health Fund - Regional health fund for Vorarlberg.
• Carinthia Health Fund (KGF/KTN)coreStrategic or Co-development PartnerCarinthia Health Fund (Kärntner Gesundheitsfonds) - Regional health fund for Carinthia.
• Styria Health Portal (GHPF)coreStrategic or Co-development PartnerStyria Health Portal - Regional health information and coordination body for Styria.
• Burgenland Health Fund (BURGEF)coreStrategic or Co-development PartnerBurgenland Health Fund - Regional health fund for Burgenland.
• INAHTA (International Network of Agencies for Health Technology Assessment)coreStrategic or Co-development PartnerInternational Network of Agencies for Health Technology Assessment - Global network enabling collaboration and knowledge sharing among HTA agencies worldwide.
• EUnetHTA (European Network for Health Technology Assessment)coreStrategic or Co-development PartnerEuropean Network for Health Technology Assessment - European collaboration on HTA methodology and joint assessments under the EU HTA Regulation.
• EBM Netzwerk (Evidence-Based Medicine Network Germany)minorStrategic or Co-development PartnerEvidence-Based Medicine Network Germany - Collaboration on evidence-based medicine methodologies.
• FALCO Project Consortium (EU Horizon Europe)minorStrategic or Co-development PartnerEU Horizon Europe project FALCO (Fighting Addictions, improving Lives: Comprehensive drug rehabilitation with music) involving seven countries for music therapy evaluation in substance use disorders.

Scale indicators4 records

Recent moves7 records

Expansion highlights6 records

Market position

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• YouTubeyoutu.be/uELBt1TX8VE
• LinkedInlinkedin.com/company/hta-austria-austrian-institute-for-health-technology-assessment-gmbh-aihta

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Hta Austria - Austrian Institute For Health Technology Assessment Gmbh (aihta)